Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/7/2018
NMPA Withdraws Approvals of Six Drugs Including Four Import Drugs
9/6/2018
Eisai and MSD Announce NMPA Approval of HCC Drug LENVIMA
9/5/2018
NMPA Approves Alexion's Orphan Drug Soliris (Eculizumab)
9/5/2018
Chi-Med Announces Chinese Approval of CRC Drug Fruquintinib
9/5/2018
Minomic Secures Key Patent in the U.S. and China
9/4/2018
IQVIA: Chinese Hospital Drug Market Up 3.7% in MAT Q1/2018
9/3/2018
Listed Chinese Healthcare Cos Witness Best Performance in Nine Years
8/31/2018
Recent Executive Moves
8/31/2018
Financial-related Company News in Brief
8/30/2018
Final Government Reorganization Plan Unveils Regulatory Roles of SAMR ...
8/30/2018
New English Name of China's Drug Watchdog Confirmed to be NMPA
8/30/2018
NYT: China Withholds H7N9 Bird Flu Sample
8/29/2018
State Council Issues Notice for Major Tasks of Healthcare Reform in H2...
8/29/2018
CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China
8/29/2018
Bloomburg: Wall Street Expats Angle for Piece of China’s Biotech Drug...
8/28/2018
Premier Li Keqiang Orders Reinforced Healthcare Reform
8/28/2018
I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes Drug
8/28/2018
China Biologic Turns Down Buyout Proposal from CEO-led Consortium
8/27/2018
Harbour BioMed Raises $85M in Series B Financing to Accelerate Its Inn...
8/27/2018
FT: China Health Reforms Help Global Pharma Groups Despite Price Cuts?
8/24/2018
Recent Executive Moves
8/24/2018
CDH-backed Mabpharm Files for Hong Kong IPO
8/22/2018
Chinese VC GL Capital Buys 5% Stake in Oxford Biodynamics
8/22/2018
USFDA Recalls Thyroid Drugs Containing Chinese API over GMP and Qualit...
8/21/2018
BMS's Opdivo To Be Priced in China at Half Cost in the U.S.
8/21/2018
The Impact of Scientific Data Administrative Measures on Foreign Compa...
8/21/2018
Fitch: Healthcare Reforms in China Present Upside Potential amid Indus...
8/20/2018
Harbour BioMed Licenses Ex-China Rights of PD-L1 Inhibitor from Sichua...
8/20/2018
Bio-Thera Announces CNDA Acceptance of Biologics Application for Humir...
8/20/2018
SMIA Announces Scope of BMI Anticancer Reimbursement Negotiation
Page:
133
/
334
Total number of articles:
9998
:
[First]
[<<]
[131]
[132]
[133]
[134]
[135]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit